Viability of Allogeneic Bone Marrow Stromal Cells following Local Delivery into Patella Tendon in Rabbit Model

Bone marrow stromal cells are potentially useful for tendon repair and regeneration. To provide lasting benefits, the seeded cells must survive implantation at local tendon sites. Our objective was to determine the in vivo fate of allogeneic bone marrow stromal cells (bMSCs) at different time points after implantation into patella tendon defects (i.e., at 2, 3, 5, and 8 weeks). The protocol involved the labeling of bMSCs with green fluorescent protein (GFP) or carboxyfluorescein diacetate (CFDA) before implantation. A window defect (5 × 5 mm) was created at the central portion of rabbit patella tendon and subsequently treated with GFP- or CFDA-marked bMSCs. The marked bMSCs were loaded into the window defect with fibrin glue. Upon sacrifice of the rabbits at the different time points, the implant site of the patellar tendon was immediately retrieved and the viability of the labeled cells was assessed under confocal microscopy. The results showed that the seeded bMSCs remained viable within the tendon wound site for at least 8 weeks after implantation. The cell morphology was changed from a round shape at 2 weeks to a spindle shape at 5 weeks after implantation. This study demonstrated that the bMSCs remained viable for prolonged periods after implantation and therefore have the potential to influence the formation and remodeling of neotendon tissue after tendon repair.

[1]  A I Caplan,et al.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. , 1995, Bone marrow transplantation.

[2]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[3]  D. Butler,et al.  Use of mesenchymal stem cells in a collagen matrix for achilles tendon repair , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  D L Butler,et al.  Autologous mesenchymal stem cell-mediated repair of tendon. , 1999, Tissue engineering.

[5]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[6]  D. Gazit,et al.  Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy , 1999, The journal of gene medicine.

[7]  M. Streit,et al.  Apligraf – a Living Human Skin Equivalent for the Treatment of Chronic Wounds , 2000, The International journal of artificial organs.

[8]  M. Pittenger,et al.  Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. , 2000, Current topics in microbiology and immunology.

[9]  Alan W. Flake,et al.  Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.

[10]  G. Im,et al.  Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. , 2001, The Journal of bone and joint surgery. British volume.

[11]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[12]  T. A. Hewett,et al.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. , 2001, Experimental hematology.

[13]  William H. Eaglstein,et al.  Tissue-Engineered Skin , 2001 .

[14]  T. Steele,et al.  Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors , 2001, The Anatomical record.

[15]  K. Fukuda,et al.  Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. , 2001, Artificial organs.

[16]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.

[17]  L. Shihabuddin,et al.  Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. , 2002, Tissue engineering.

[18]  Xian-Yang Zhang,et al.  Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Ivan Martin,et al.  The FASEB Journal express article 10.1096/fj.01-0656fje. Published online December 28, 2001. Cell differentiation by mechanical stress , 2022 .

[20]  Swee Hin Teoh,et al.  The Efficacy of Bone Marrow Stromal Cell‐Seeded Knitted PLGA Fiber Scaffold for Achilles Tendon Repair , 2002, Annals of the New York Academy of Sciences.

[21]  S. Teoh,et al.  Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon. , 2003, Tissue engineering.

[22]  H. Ouyang,et al.  Use of Bone Marrow Stromal Cells for Tendon Graft-to-Bone Healing , 2004, The American journal of sports medicine.